BKI-1369 Catalog No.:M31153-C Smiles: COC1=CC=C(C=C1O)/C=C/C1C=C(C=C(O)C=1)O[C@@H]1O[C@H](COC(=O)C2=CC(O)=C(O)C(O)=C2)[C@@H](O)[C@H](O)[C@H]1O

Smiles: COC1=CC=C(C=C1O)/C=C/C1C=C(C=C(O)C=1)O[C@@H]1O[C@H](COC(=O)C2=CC(O)=C(O)C(O)=C2)[C@@H](O)[C@H](O)[C@H]1O

05) do not differ between the AAA model group and Tauroursodeoxycholate group

exhibits protective effects against H2O2-induced myocardial cell injury

Formula: C69H124N22O19

BKI-1369 Catalog No.:M31153-C Smiles: COC1=CC=C(C=C1O)/C=C/C1C=C(C=C(O)C=1)O[C@@H]1O[C@H](COC(=O)C2=CC(O)=C(O)C(O)=C2)[C@@H](O)[C@H](O)[C@H]1OBKI 1369 is a bumped kinase inhibitor (BKI). BKI 1369 increases human Ether a go go related gene (hERG) inhibitory activity with an IC50 of 1. 52 M. BKI 1369 reduces the parasite burden and diseases severity in the gnotobiotic pig model. BKI 1369 has been well characterized for potency, stability, metabolism, toxicity, pharmacokinetics and is potent against C. parvum in infected mice and calves. Product information CAS Number: 1951431 22 3 Molecular